Impact Metrics BioRegió 2015
•
1 like•292 views
The BioRegion of Catalonia is a major life sciences research and innovation hub in Southern Europe, home to 560 companies, 56 research centers, 17 university hospitals, and 11 universities. Biocat coordinates and promotes the life sciences sector, supporting over 3,500 companies that employ over 90,000 workers and contribute 6% to Catalonia's GDP. Catalonia has a strong R&D ecosystem and is highly internationalized, with 65% of life sciences companies trading abroad and ranking 2nd in the EU for European Research Council grants per capita.
Impact Metrics BioRegió 2015
- 2. THEBIOREGIONOFCATALONIA ARESEARCHANDINNOVATIONHUBINSOUTHERNEUROPECatalonia is the most dynamic bioregion in Spain. The BioRegion of Catalonia brings together 560 companies as well as 56 research centers, 17 university hospitals and 11 universities offering studies in the life sciences. 16 science and technology parks with activity in the life sciences, more than 100 scientific platforms and large research facilities like the Alba-Cells Synchrotron, the Barcelona Supercomputing Center (BSC) and the National Center for Genomic Analysis (CNAG) make Catalonia and its capital, Barcelona, an outstanding research and innovation hub in southern Europe. BIOCAT,DRIVINGTHEBIOCLUSTERBiocat is the organization that coordinates and promotes the life sciences sector in Catalonia. Biocat’s mission is to support and dynamize all the stakeholders in this area to boost research, innovation and companies’ growth in order to make the life sciences a driving force for the country’s economy and contribute to the wellbeing of society as a whole. Created in 2006 at the behest of the Government of Catalonia and the Barcelona City Council, Biocat is a foundation that brings together representatives from all areas of the biotechnology, biomedicine and medical technology sector: administrations, universities, research centers, companies and support bodies.
- 3. UNIVERSITIES(OUTOF12) OFFERINGSTUDIESIN LIFESCIENCES 11 LARGERESEARCH FACILITIES 2 UNIVERSITYHOSPITALS17 RESEARCHINSTITUTES (OUTOF66) 56 TECHNOLOGICAL CENTERS 12 SCIENCE& TECHNOLOGYPARKS 16 64 MEDTECH 39 PHARMA 124 SUPPLIER &ENGINEERING 25 INVESTORS PROFESSIONAL SERVICESAND CONSULTING 111 BIOTECH197 11 2 17 56 12 16 64 39 124 25 111 197 114RESEARCH ORGANIZATIONS 560COMPANIES Source: Biocat Directory (December 2014) AWIDEECOSYSTEMWHERESCIENCEANDBUSINESSMEET
- 4. Sources: Biocat Directory (Dec. 2014), Catalan Union of Hospitals, Government of Catalonia and SABI EMPLOYMENTANDRESOURCES COMPANIES RESEARCHCENTERS HOSPITALS 3.500 7.200WORKERS +90.000WORKERS(PUBLIC PROVIDERS) 4.500RESEARCHERS RESEARCHERS INBIOMEDICINE 35.000 PHARMA 13.800 BIOTECH 8.500 OTHERS 6.300 MEDTECH 6.400 WORKERS COMPANIESHADREVENUES OVER11.000M€AND CONTRIBUTEDWITH6% TOTHEGDPINCATALONIA IN10YEARS,HUMANRESOURCESINR&DHAVE INCREASED50%ANDTHERESEARCHCOMMUNITY60%
- 5. Source: FECYT, Farmaindustria, INE (2013) INVESTMENTINCATALONIAINR&D €345M PHARMA INDUSTRY €147M BIOTECH COMPANIES € 681M UNIVERSITIES
- 6. FINANCE PRIVATEINVESTMENTSINCATALANLIFESCIENCECOMPANIES MAB* VENTURE CAPITAL Source: BiotechGate. Biocat Directory IN MILLION EUROS / *MAB: Spanish sub-market for smaller, growing companies 35 30 25 20 15 10 5 0 2013 25.6 3.6 2012 18 5 2008 12,4 12.4 2010 6.6 2009 5.6 2011 12.9 4.3
- 7. ANINTERNATIONALCOMPETITIVER&DSYSTEM Source: Government of Catalonia 1 2 3 2 UNIVERSITIES AMONG THE 200 BEST IN THE WORLD 3 UNIVERSITIES AMONG THE 50 BEST UNDER 50 YEARS 19TH BEST STUDENT CITY OF THE WORLD BARCELONA1 UNIVERSITY AMONG THE 60 TOP UNIVERSITIES IN THE WORLD IN SCIENTIFIC PRODUCTION CRG 9TH IN THE TOP 100 BEST BIOMEDICAL CENTERS IN THE WORLD Scimago Report (SIR 2013) ICIQ 1ST WORLD INSTITUTION IN CHEMISTRY Max Plank Institute (2014) ICFO 1ST WORLD INSTITUTION IN PHYSICS Max Plank Institute (2013) URAP (2014) ARWU AND QS (2014) QS TOP-50 UNIVERSITIES UNDER 50 YEARS (2014) QS BEST STUDENTS CITIES 2015
- 8. EUROPEANRESEARCHCOUNCILGRANTS(ERC) PERMILLIONINHABITANTS(2007-2014) Source: Government of Catalonia SWITZERLAND* ISRAEL* NETHERLANDS CATALONIA SWEDEN DENMARK UNITED KINGDOM FINLAND BELGIUM CYPRUS AUSTRIA IRELAND FRANCE NORWAY GERMANY EUROPEAN UNION EUROPEAN RESEARCH AREA SPAIN ITALY HUNGARY PORTUGAL SPAIN EXCLUDING CATALONIA GREECE COUNTRY ERCGRANTS 39.3 34.1 25.1 20.4 5.9 7.4 7.9 3.2 CATALONIASTANDS IN2ND POSITIONIN THEEUROPEAN UNIONINTERMSOF ERCGRANTS 17.3 16.8 15.7 14.0 13.5 12.8 12.7 10.7 9.1 8.5 7.9 4.5 4.0 3.7 3.1 *NON-EU COUNTRIES
- 10. SUBSECTOROFACTIVITYOFMEDTECHCOMPANIES Source: Biocat Directory (December 2014) EACH COMPANY MAY BE INCLUDED INTO MORE THAN ONE CATEGORY REUSABLE INSTRUMENTS NON-ACTIVE IMPLANTABLE DEVICES ELECTRO MECHANICAL MEDICAL DEVICES DENTAL DEVICES SINGLE USE DEVICES OPHTHALMIC AND OPTICAL DEVICES IMAGING ANESTHETIC AND RESPIRATORY DEVICES HOSPITAL HARDWARE BIOMATERIALS IN VITRO DIAGNOSTICS DEVICES DIAGNOSTIC AND THERAPEUTIC RADIATION DEVICES TECHNICAL AIDS FOR DISABLED PERSONS REGENERATIVE MEDICINE WOUND CARE DELIVERY DEVICES OTHER THERAPEUTICAREAS NUMBEROFCOMPANIES 23 16 16 13 11 11 11 9 6 6 5 5 3 3 2 2 COMPANIESWORKINGINMEDTECH: 16 64 45 DEVELOP R&D FOR NEW MEDICAL AND DIAGNOSTIC DEVICES WORK IN RELATED AREAS LIKE SOFTWARE, ELECTRONICS, INSTRUMENTATION OR DISTRIBUTION 109
- 11. MAINTHERAPEUTICAREAS(BIOTECH&PHARMA) Source: Biocat Directory (December 2014) CENTRAL NERVOUS SYSTEM ONCOLOGY CARDIOVASCULAR DISEASES INFECTIOUS DISEASES DERMATOLOGY IMMUNOLOGY AND HEMATOLOGY RESPIRATORY INFLAMMATORY DISEASES ENDOCRINOLOGY MENTAL DISORDERS GENITOURINARY SYSTEM OPHTHALMOLOGY DIGESTIVE SYSTEM OBSTETRICS & GYNECOLOGY OTOLOGY THERAPEUTICAREAS NUMBEROFCOMPANIES 27 22 19 18 17 14 14 14 13 11 9 7 7 2 1 EACH COMPANY MAY BE INCLUDED INTO MORE THAN ONE CATEGORY
- 12. BIOTECHCOMPANIESACTIVITIES Source: Biocat Directory (December 2014) THERAPIES & DIAGNOSTICS R&D SERVICES BIOTECH-OTHER* ACTIVITIES NUMBEROFCOMPANIES 49 72 76 *EACH COMPANY MAY BE INCLUDED INTO MORE THAN ONE CATEGORY BIOTECH-OTHER* 45% 35% 11% 11% 14% 8% VETERINARY FOOD & NUTRACEUTICALS AGROBIO COSMETICS INDUSTRIAL BIOTECHNOLOGY ENVIRONMENTAL
- 13. 65%OFCATALANBIOTECH,PHARMAANDMEDTECH COMPANIESARETRADINGTHEIRPRODUCTSIN INTERNATIONALMARKETS Source: Biocat's Internationalization Survey, 2013 30% 25% 20% 15% 10% 5% 0% France Germany United States Italy Portugal United Kingdom Japan Mexico Russian Federation Brasil Switzerland Sweden Belgium China India Percentatgeofcompanies Sales Collaborations Future entrance INTERNATIONALMARKETS
- 14. Source: Biocat Directory (December 2014) ENTREPRENEURSHIP INITIATIVESSUCHAS BIOEMPRENEDORXXI PROGRAM SUPPORTEDTHE CREATIONOF61 COMPANIES(2007-2014) 68 SPIN-OFF FROMUNIVERSITIES, RESEARCHINSTITUTES ANDHOSPITALS 25 15 22 27 27 32 28 35 20 26 36 36 38 28 18 0 40 30 20 10 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 ACLUSTERINEXPANSION NEWCOMPANIESCREATED(2000-2014)
- 15. 87%OFBIOREGIONCOMPANIESARESMEs BIGCOMPANIESAREMAINLYMULTINATIONALPHARMAS BIGCOMPANIES MEDIUM-SIZED COMPANIES SMALL COMPANIES MICRO COMPANIES 13% 19% 20% 48% COMPANIES SIZE Source: Biocat Directory (December 2014) Company category Balance sheet totalEmployees Medium-sized Small Micro < 250 < 50 < 10 ≤ € 50 m ≤ € 10 m ≤ € 2 m ≤ € 43 m ≤ € 10 m ≤ € 2 m Turnover
- 16. ABUSINESSHUBWITHBALANCEDREPRESENTATION OFALLFIELDSOFLIFESCIENCES Source: Biocat Directory (December 2014) and SABI 197BIOTECH THERAPEUTICSANDDIAGNOSTICS9% R&DSERVICES14% OTHERS13% PHARMA 7% MEDICAL TECHNOLOGY11% SUPPLIER& ENGINEERING 22% PROFESSIONAL SERVICESAND CONSULTING 20% INVESTORS 4% 49 76 72 64 39 124 111 25 THERAPEUTICSANDDIAGNOSTICS9% > €5.000M 2.5%GDPCATALONIA €154.8MINR&D 3.564EMPLOYEES(2.493INR&D) €11.500M6%GDPCATALONIA* 35.000EMPLOYEES 560COMPANIES